Skip to main content

Table 4 Multivariate-Cox-regression-analysis for disease-free survival and overall-survival of breast-cancer patients

From: Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications

   DFS    OS  
  HR 95% CI p HR 95% CI P
Tumor stage 0,807 0,435–1,496 0,496 1,393 0,658–2,948 0,386
Lymph node status 6,737 2,607–17,409 0,000 5,99 1,920–18,688 0,002
ER/PR status 0,405 0,196–0,837 0,015    
M3H67 reactivity 4,355 1,218–15,572 0,024 7,693 2,597–22,786 0,000
57B reactivity 1,328 0,229–7,713 0,752 0,71 0,120–4,216 0,706
  1. Abbreviations: DFS Disease free survival; OS Overall survival; HR Hazard ratio; CI Confidence interval.